Pregled bibliografske jedinice broj: 1133809
An Overview of the Role of Long Non-Coding RNAs in Human Choriocarcinoma
An Overview of the Role of Long Non-Coding RNAs in Human Choriocarcinoma // International journal of molecular sciences, 22 (2021), 12; 6506, 16 doi:10.3390/ijms22126506 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 1133809 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
An Overview of the Role of Long Non-Coding RNAs in
Human Choriocarcinoma
Autori
Di Fiore, Riccardo ; Suleiman, Sherif ; Felix, Ana ; O'Toole, Sharon ; O'Leary, John J ; Ward, Mark P ; Beirne, James ; Sabol, Maja ; Ozretić, Petar ; Yordanov, Angel ; Vasileva-Slaveva, Mariela ; Kostov, Stoyan ; Nikolova, Margarita ; Said-Huntingford, Ian ; Ayers, Duncan ; Ellul, Bridget ; Pentimalli, Francesca ; Giordano, Antonio ; Calleja-Agius, Jean
Izvornik
International journal of molecular sciences (1422-0067) 22
(2021), 12;
6506, 16
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
choriocarcinoma ; rare cancer ; long non-coding RNA ; oncogenes or tumor suppressor genes ; lncRNA-based therapy
Sažetak
Choriocarcinoma (CC), a subtype of trophoblastic disease, is a rare and highly aggressive neoplasm. There are two main CC subtypes: gestational and non-gestational, (so called when it develops as a component of a germ cell tumor or is related to a somatic mutation of a poorly differentiated carcinoma), each with very diverse biological activity. A therapeutic approach is highly effective in patients with early-stage CC. The advanced stage of the disease also has a good prognosis with around 95% of patients cured following chemotherapy. However, advancements in diagnosis and treatment are always needed to improve outcomes for patients with CC. Long non-coding (lnc) RNAs are non-coding transcripts that are longer than 200 nucleotides. LncRNAs can act as oncogenes or tumor suppressor genes. Deregulation of their expression has a key role in tumor development, angiogenesis, differentiation, migration, apoptosis, and proliferation. Furthermore, detection of cancer-associated lncRNAs in body fluids, such as blood, saliva, and urine of cancer patients, is emerging as a novel method for cancer diagnosis. Although there is evidence for the potential role of lncRNAs in a number of cancers of the female genital tract, their role in CC is poorly understood. This review summarizes the current knowledge of lncRNAs in gestational CC and how this may be applied to future therapeutic strategies in the treatment of this rare cancer.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb
Poveznice na cjeloviti tekst rada:
Pristup cjelovitom tekstu rada doi www.mdpi.com doi.org fulir.irb.hrCitiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE